State Street’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-11,077
Closed -$71K 3808
2018
Q4
$71K Buy
11,077
+749
+7% +$4.79K ﹤0.01% 3657
2018
Q3
$73K Sell
10,328
-39,900
-79% -$300K ﹤0.01% 3673
2018
Q2
$477K Sell
50,228
-7,739
-13% -$74.1K ﹤0.01% 3477
2018
Q1
$592K Buy
57,967
+648
+1% +$6.62K ﹤0.01% 3419
2017
Q4
$571K Sell
57,319
-16,466
-22% -$180K ﹤0.01% 3430
2017
Q3
$820K Buy
73,785
+43,729
+145% +$512K ﹤0.01% 3414
2017
Q2
$284K Buy
30,056
+506
+2% +$4.04K ﹤0.01% 3503
2017
Q1
$197K Buy
29,550
+830
+3% +$4.92K ﹤0.01% 3506
2016
Q4
$176K Buy
28,720
+836
+3% +$4.16K ﹤0.01% 3506
2016
Q3
$143K Sell
27,884
-1,111
-4% -$5.92K ﹤0.01% 3421
2016
Q2
$167K Buy
28,995
+762
+3% +$4.64K ﹤0.01% 3519
2016
Q1
$172K Sell
28,233
-1,164
-4% -$6.95K ﹤0.01% 3502
2015
Q4
$187K Buy
29,397
+588
+2% +$3.71K ﹤0.01% 3492
2015
Q3
$173K Sell
28,809
-1,008
-3% -$6.26K ﹤0.01% 3486
2015
Q2
$183K Buy
29,817
+424
+1% +$2.6K ﹤0.01% 3492
2015
Q1
$151K Sell
29,393
-25,633
-47% -$126K ﹤0.01% 3515
2014
Q4
$248K Buy
55,026
+25,725
+88% +$122K ﹤0.01% 3488
2014
Q3
$144K Buy
29,301
+9,329
+47% +$45.2K ﹤0.01% 3498
2014
Q2
$110K Sell
19,972
-1,344
-6% -$6.04K ﹤0.01% 3464
2014
Q1
$85K Buy
+21,316
New +$86.6K ﹤0.01% 3515

Other funds holding CO

State Street's CO Position: Q1 2019 in Review

State Street sold out of Global Cord Blood Corporation (CO) in Q1 2019, closing a stake of 11,077 shares — an estimated $71K sold.

State Street first reported a position in CO in Q1 2014 and held it in 20 quarters. The position peaked at $820K in Q3 2017. 39 funds tracked by Wall St. Rank hold CO as of Q1 2019.

  • State Street reported no remaining Global Cord Blood Corporation position as of Q1 2019 after selling out during the quarter.
  • State Street sold 11,077 Global Cord Blood Corporation shares in Q1 2019, an estimated $71K.
  • State Street first reported a position in Global Cord Blood Corporation in Q1 2014 and held it in 20 quarters.
  • State Street's Global Cord Blood Corporation position peaked at $820K in Q3 2017.
  • 39 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q1 2019.

Based on State Street's 13F filing for Q1 2019, filed 15 May 2019.